Teva Pharmaceutical Industries Ltd. ADR (TEVA)
NYSE
Closed
Aug 24, 2026
Day's Range
36.7652 wk Range
17.82Overview - TEVA - Teva Pharmaceutical Industries Ltd. ADR
Key Statistics
Valuation
Enterprise Value
56.75B
P/E (Trailing)
‪62.23‬
P/E (Forward)
‪12.14‬
PEG Ratio
‪-0.21‬
Price / Sales (TTM)
‪2.51‬
Price / Book
‪5.61‬
EV / EBITDA
‪13.29‬
Profitability
Gross Margin
‪51.97%‬
Profit Margin
‪4.07%‬
Operating Margin
‪4.03%‬
Return on Assets
‪5.12%‬
Return on Equity
‪9.69%‬
Ownership
Shares Outstanding
1.16B
Float
1.08B
Short % of Shares Outstanding
‪2.96%‬
Held by Insiders
‪0.0040%‬
Held by Institutions
‪64.49%‬
Price stats
Beta
‪0.87‬
50-Day Avg
‪33.88‬
200-Day Avg
‪31.95‬
Dividends
Payout Ratio
‪0.00%‬
Frequency
Quarterly
Analyst Consensus
12 analysts
Market Cap - TEVA - Teva Pharmaceutical Industries Ltd. ADR
Peers - TEVA - Teva Pharmaceutical Industries Ltd. ADR
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on NYSE.
- TEVANYSETeva Pharmaceutical Industries Ltd. ADR42.48BMarket Cap+51.84%52-week change61.28P/E (Trailing)‪4.07%‬Profit Margin
- MRKNYSEMerck & Co., Inc.376.36BMarket Cap+43.05%52-week change122.04P/E (Trailing)‪4.76%‬Profit Margin
- PWRNYSEQuanta Services Inc.96.12BMarket Cap+38.73%52-week change72.98P/E (Trailing)‪4.03%‬Profit Margin
- CLNYSEColgate-Palmolive Company72.60BMarket Cap+7.71%52-week change35.86P/E (Trailing)‪9.68%‬Profit Margin
- SENYSESea Ltd.71.98BMarket Cap-59.58%52-week change45.38P/E (Trailing)‪5.90%‬Profit Margin
- DBNYSEDeutsche Bank AG71.06BMarket Cap+2.33%52-week change9.87P/E (Trailing)‪22.71%‬Profit Margin
- HLNNYSEHaleon Plc - ADR44.68BMarket Cap+4.72%52-week change20.41P/E (Trailing)‪14.55%‬Profit Margin
Profile Summary - TEVA - Teva Pharmaceutical Industries Ltd. ADR
About
Teva Pharmaceutical Industries Ltd. ADR represents shares of an Israeli-based global pharmaceutical company focused on developing, manufacturing, and marketing medicines across multiple therapeutic areas. Teva is widely recognized for its large portfolio of generic drugs, which provide cost-effective alternatives to…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
